Allosteric modulation of protease-activated receptor signaling

Mini-Reviews in Medicinal Chemistry

Volumn 12, Issue 9, 2012, Pages 804-811

  Canto, I ^a,b   Soh, U J K ^a   Trejo, J ^a  

^a San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Caveolae; G protein; GPCR; Palmitoylation; Thrombin

Indexed keywords

ACTIVATED PROTEIN C; BETA ARRESTIN; DISHEVELLED 2; ENDOTHELIAL PROTEIN C RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MU OPIATE RECEPTOR; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHODOPSIN; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TRANSDUCIN; YELLOW FLUORESCENT PROTEIN;

ALLOSTERISM; AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM MOBILIZATION; CAVEOLA; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CRYSTAL STRUCTURE; DIMERIZATION; ENDOTHELIUM CELL; ENERGY TRANSFER; HUMAN; INTERNALIZATION; INTRACELLULAR SIGNALING; PALMITOYLATION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ALLOSTERIC REGULATION; CELL TRANSFORMATION, NEOPLASTIC; EMBRYONIC DEVELOPMENT; HEMOSTASIS; HUMANS; PEPTIDES; PROTEIN ISOFORMS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; RECEPTORS, PROTEINASE-ACTIVATED; SIGNAL TRANSDUCTION; THROMBIN; THROMBOSIS;

EID: 84862848502     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955712800959116     Document Type: Article

References (71)

1. Kenakin, T., Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther., 2011, 336 (2), 296-302.
2. Urban, J. D.; Clarke, W. P.; von Zastrow, M.; Nichols, D. E.; Kobilka, B.; Weinstein, H.; Javitch, J. A.; Roth, B. L.; Christopoulos, A.; Sexton, P. M.; Miller, K. J.; Spedding, M.; Mailman, R. B., Functional Selectivity and Classical Concepts of Quantitative Pharmacology. J. Pharmacol. Exp. Ther., 2007, 320, 1-13.
3. Vu, T. K.; Hung, D. T.; Wheaton, V. I.; Coughlin, S. R., Molecular cloning of a functional thrombin receptor reveals a novel proteolysis mechanism of receptor activation. Cell, 1991, 64, 1057-1068.
4. Vu, T. K.; Wheaton, V. I.; Hung, D. T.; Coughlin, S. R., Domains specifying thrombin-receptor interaction. Nature, 1991, 353, 674-677.
5. Rydel, T. J.; Ravichandran, K. G.; Tulinsky, A.; Bode, W.; Huber, R.; Roitsch, C.; Fenton, J., The structure of a complex of recombinant hirudin and human alpha-thrombin. Science, 1990, 249 (4966), 277-280.
6. Baffy, G.; Yang, L.; Raj, S.; Manning, D. R.; Williamson, J. R., G protein coupling to the thrombin receptor in Chinese hamster lung fibroblasts. J. Biol. Chem., 1994, 269, 8483-8487.
7. Offermanns, S.; Toombs, C. F.; Hu, Y. H.; Simon, M. I., Defective platelet activation in G alpha(q)-deficient mice. Nature, 1997, 389, 183-186.
8. Offermanns, S.; Laugwitz, K.-L.; Spicher, K.; Schultz, G., G proteins of the G12 family are activated via thromboxane A2 andthrombin receptors in human platelets. Proc. Natl. Acad. Sci. USA, 1994, 91, 504-508.
9. Lopez, I.; Mak, E. C.; Ding, J.; Hamm, H. E.; Lomasney, J. W., Anovel bifunctional phospholipase C that is regulated by G alpha 12and stimulates the ras/mitogen-activated protein kinase pathway. J. Biol. Chem., 2001, 276, 2758-2765.
10. DeFea, K. A.; Zalevski, J.; Thoma, M. S.; Dery, O.; Mullins, R. D.; Bunnett, N. W., Arrestin-dependent Endocytosis of Proteinaseactivated Receptor-2 Is Required for Intracellular Targeting of Activated ERK1/2. J. Cell Biol., 2000, 148, 1267-1281.
11. Stalheim, L.; Ding, Y.; Gullapalli, A.; Paing, M. M.; Wolfe, B. L.; Morris, D. R.; Trejo, J., Multiple independent functions of arrestins in regulation of protease-activated receptor-2 signaling and trafficking. Mol. Pharm., 2005, 67, 1-10.
12. Verrall, S.; Ishii, M.; Chen, M.; Wang, L.; Tram, T.; Coughlin, S. R., The thrombin receptor second cytoplasmic loop confers coupling to Gq-like G proteins in chimeric receptors. Additional evidence for a common transmembrane signaling and G protein coupling mechanism in G protein-coupled receptors. J. Biol. Chem., 1997, 272 (11), 6898-902.
13. Chen, J.; Ishii, M.; Wang, L.; Ishii, K.; Coughlin, S. R., Thrombin receptor activation: Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J. Biol. Chem., 1994, 269, 16041-16045.
14. Angers, S.; Salahpour, A.; Joly, E.; Hilairet, S.; Chelsky, D.; Dennis, M.; Bouvier, M., Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci U S A, 2000, 97 (7), 3684-3689.
15. Ayoub, M. A.; Trinquet, E.; Pfleger, K. D.; Pin, J. P., Differential association modes of the thrombin receptor PAR1 with Galphai1,Galpha12, and beta-arrestin 1. FASEB J., 2010, 24 (9), 3522-3535.
16. Ayoub, M. A.; Maurel, D.; Binet, V.; Fink, M.; Prezeau, L.; Ansanay, H.; Pin, J. P., Real-time analysis of agonist-induced activation of protease-activated receptor-1/Galphai protein complex measured by bioluminescence resonance energy transfer in living cells. Mol Pharm., 2007, 71, 704-712.
17. McLaughlin, J. N.; Shen, L.; Holinstat, M.; Brooks, J. D.; DiBenedetto, E.; Hamm, H. E., Functional Selectivity of G Protein Signaling by Agonist Peptides and Thrombin for the Proteaseactivated Receptor-1. J. Biol. Chem., 2005, 280, 25048-25059.
18. Kim, Y. V.; Di Cello, F.; Hillaire, C. S.; Kim, K. S., Differential Ca2+ signaling by thrombin and protease-activated receptor-1-activating peptide in human brain microvascular endothelial cells. Am. J. Physiol. Cell Physiol., 2004, 286 (1), C31-C42.
19. Blackhart, B. D.; Ruslim-Litrus, L.; Lu, C. C.; Alves, V. L.; Teng, W.; Scarborough, R. M.; Reynolds, E. E.; Oksenberg, D., Extra cellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide. Mol Pharm., 2000, 58, 1178-1187.
20. Lerner, D. J.; Chen, M.; Tram, T.; Coughlin, S. R., Agonistrecognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function. J. Biol. Chem., 1996, 271 (24), 13943-13947.
21. Al-Ani, B.; Wijesuriya, S. J.; Hollenberg, M. D., Proteinaseactivated receptor 2: differential activation of the receptor by tethered ligand and soluble peptide analogs. J. Pharmacol. Exp. Ther., 2002, 302 (3), 1046-1054.
22. Ramachandran, R.; Mihara, K.; Mathur, M.; Rochdi, M. D.; Bouvier, M.; Defea, K.; Hollenberg, M. D., Agonist-biasedsignaling via proteinase activated receptor-2: differential activationof calcium and mitogen-activated protein kinase pathways. Mol. Pharmacol., 2009, 76 (4), 791-801.
23. Ishihara, H.; Connolly, A. J.; Zeng, D.; Kahn, M. L.; Zheng, Y. W.; Timmons, C.; Tram, T.; Coughlin, S. R., Protease-activated receptor 3 is a second thrombin receptor in humans. Nature, 1997, 386, 502-506.
24. Bretschneider, E.; Spanbroek, R.; Lotzer, K.; Habenicht, A. J.; Schror, K., Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells. Thromb. Haemost., 2003, 90 (4), 704-79.
25. Seminario-Vidal, L.; Kreda, S.; Jones, L.; O'Neal, W.; Trejo, J.; Boucher, R. C.; Lazarowski, E. R., Thrombin promotes release of ATP from lung epithelial cells through coordinated activation of Rho-and Ca2+-dependent signaling pathways. J. Biol. Chem., 2009, 284, 20638-20648.
26. McLaughlin, J. N.; Patterson, M. M.; Malik, A. B., Protease activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci U S A, 2007, 104, 5662-5667.
27. O'Brien, P. J.; Prevost, N.; Molino, M.; Hollinger, M. K.; Woolkalis, M. J.; Woulfe, D. S.; Brass, L. F., Thrombin Responses in Human Endothelial Cells. Contributions from receptors other than PAR1 include transactivation of PAR2 by thrombin-cleaved PAR1. J. Biol. Chem., 2000, 275, 13502-13509.
28. Kaneider, N. C.; Leger, A. J.; Agarwal, A.; Nguyen, N.; Perides, G.; Derian, C.; Covic, L.; Kuliopulos, A., Role reversal for the receptor PAR1 in sepsis-induced vascular damage. Nat. Immunol., 2007, 12, 1303-1312.
29. Nakanishi-Matsui, M.; Zheng, Y.-W.; Weiss, E. J.; Sulciner, D.; Coughlin, S. R., PAR3 is a cofactor for PAR4 activation by thrombin. Nature, 2000, 404, 609-613.
30. Kahn, M. L.; Zheng, Y. W.; Huang, W.; Bigornia, V.; Zeng, D.; Moff, S.; Farese, R. V., Jr.; Tam, C.; Coughlin, S. R., A dual thrombin receptor system for platelet activation. Nature, 1998, 394 (6694), 690-694.
31. Faruqi, T. R.; Weiss, E. J.; Shapiro, M. J.; Huang, W.; Coughlin, S. R., Structure-function analysis of protease-activated receptor-4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function. J. Biol. Chem., 2000, 275, 19728-19734.
32. Shapiro, M. J.; Weiss, E. J.; Faruqi, T. R.; Coughlin, S. R., Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J. Biol. Chem., 2000, 275, 25216-25221.
33. Voss, B.; McLaughlin, J. N.; Holinstat, M.; Zent, R.; Hamm, H. E.,PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axis. Mol. Pharmacol., 2007, 71 (5), 1399-1406.
34. Hirano, K.; Nomoto, N.; Hirano, M.; Momota, F.; Hanada, A.; Kanaide, H., Distinct Ca2+ requirement for NO production between proteinase-activated receptor 1 and 4 (PAR1 and PAR4) in vascular endothelial cells. J. Pharmacol. Exp. Ther., 2007, 322 (2),668-677.
35. Kenakin, T., New concepts in drug discovery: collateral efficacy and permissive antagonism. Nat. Rev. Drug Discov., 2005, 4 (11), 919-927.
36. Russo, A.; Soh, U. J.; Trejo, J., Proteases display biased agonism at protease-activated receptors: location matters! Mol. Interv., 2009, 9 (2), 87-96.
37. Komarova, Y. A.; Mehta, D.; Malik, A. B., Dual regulation of endothelial junctional permeability. Sci. STKE, 2007, (412), p. re8.
38. Feistritzer, C.; Riewald, M., Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine-1- phosphate receptor-1 crossactivation. Blood, 2005, 105 (8), 3178-3184.
39. Finigan, J. H.; Dudek, S. M.; Singleton, P. A.; Chiang, E. T.; Jacobson, J. R.; Camp, S. M.; Ye, S. Q.; Garcia, J. G. N., Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement. J. Biol. Chem., 2005, 280, 17286-17293.
40. Russo, A.; Soh, J. K.; Paing, M. M.; Arora, P.; Trejo, J., Caveolae are required for protease-selective signaling by protease-activated receptor-1. Proc. Natl. Acad. Sci. U S A, 2009, 106, 6393-6397.
41. Kerschen, E.J.; Fernandez, J.A.; Cooley, B.C.; Yang, X.V.; Sood, R.; Mosnier, L.O.; Castellino, F. J.; Mackman, N.; Griffin, J.H., Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J. Exp. Med. 2007, 204 (10), 2439-2448.
42. Camerer, E.; Regard, J. B.; Cornelissen, I.; Srinivasan, Y.; Duong, D. N.; Palmer, D.; Pham, T. H.; Wong, J. S.; Pappu, R.; Coughlin, S. R., Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J. Clin. Invest., 2009, 119 (7), 1871-1879.
43. Ludeman, M. J.; Kataoka, H.; Srinivasas, Y.; Esmon, N. L.; Esmon, C. T.; Coughlin, S. R., PAR1 Cleavage and Signaling in Response to Activated Protein C and Thrombin. J. Biol. Chem., 2005, 280, 13122-13128.
44. Riewald, M.; Ruf, W., Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling. J. Biol. Chem., 2005, 280 (20), 19808-19814.
45. Bae, J.-S.; Yang, L.; Manithody, C.; Rezaie, A. R.,The ligand occupancy of endothelial protein C receptor switches the proteaseactivated receptor-1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. Blood, 2007, 110, 3909-3916.
46. Parton, R. G.; Richards, A. A., Lipid Rafts and Caveolae as Portals for Endocytosis: New Insights and Common Mechanisms. Traffic, 2003, 4, 724-738.
47. Bae, J. S.; Yang, L.; Rezaie, A. R., Lipid raft localization regulates the cleavage specificity of protease activated receptor-1 in endothelial cells. J. Thomb. Haemost., 2008, 6, 954-961.
48. Bae, J. S.; Yang, L.; Rezaie, A. R., Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc. Natl. Acad. Sci. U S A, 2007, 104 (8), 2867-2872.
49. Schuepbach, R. A.; Feistritzer, C.; Brass, L. F.; Riewald, M., Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin. Blood, 2008, 111 (5), 2667-2673.
50. Sen, P.; Gopalakrishnan, R.; Kothari, H.; Keshava, S.; Clark, C. A.; Esmon, C. T.; Pendurthi, U. R.; Rao, L. V., Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protection. Blood, 2011, 117 (11), 3199-208.
51. Awasthi, V.; Mandal, S. K.; Papanna, V.; Rao, L. V. M.; Pendurthi, U. R., Modulation of Tissue Factor-Factor VIIa Signaling by Lipid Rafts and Caveolae. Arterioscler. Thromb. Vasc. Biol., 2008, 27, 1447-1455.
52. Boire, A.; Covic, L.; Agarwal, A.; Jacques, S.; Sherifi, S.; Kuliopulos, A., PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells. Cell, 2005, 120, 303-313.
53. Nesi, A.; Fragai, M., Substrate Specificities of Matrix Metalloproteinase 1 in PAR-1 Exodomain Proteolysis. Chembiochem., 2007, 12, 1367-1369.
54. Trivedi, V.; Boire, A.; Tchernychev, B.; Kaneider, N. C.; Leger, A. J.; O'Callaghan, K.; Covic, L.; Kuliopulos, A., Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell, 2009, 137 (2), 332-343.
55. Linder, M. E.; Deschenes, R. J., Palmitoylation: policing protein stability and traffic. Nat. Rev. Mol. Cell. Biol., 2007, 8, 74-94.
56. Chini, B.; Parenti, M., G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats. J. Mol. Endocrinol., 2009, 42 (5), 371-379.
57. Kong, M. M.; Verma, V.; O'Dowd, B. F.; George, S. R., The role of palmitoylation in directing dopamine D1 receptor internalization through selective endocytic routes. Biochem. Biophys. Res. Commun., 2011, 405 (3), 445-449.
58. Renner, U.; Glebov, K.; Lang, T.; Papusheva, E.; Balakrishnan, S.; Keller, B.; Richter, D. W.; Jahn, R.; Ponimaskin, E., Localization of the mouse 5-hydroxytryptamine(1A) receptor in lipidmicrodomains depends on its palmitoylation and is involved in receptor-mediated signaling. Mol. Pharmacol., 2007, 72 (3), 502-513.
59. Papoucheva, E.; Dumuis, A.; Sebben, M.; Richter, D. W.; Ponimaskin, E. G., The 5-hydroxytryptamine(1A) receptor is stably palmitoylated, and acylation is critical for communication of receptor with Gi protein. J. Biol. Chem., 2004, 279 (5), 3280-3291.
60. Zheng, H.; Chu, J.; Qiu, Y.; Loh, H. H.; Law, P.-Y., Agonistselective signaling is determined by the receptor location within the membrane domains. Proc. Natl. Acad. Sci. U S A, 2008, 105, 9421-9426.
61. Horstmeyer, A.; Cramer, H.; Sauer, T.; Muller-Esterl, W.; Schroeder, C., Palmitoylation of endothelin of signal transduction activity by post-translational modification. J. Biol. Chem., 1996, 271 (34), 20811-28019.
62. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M., Crystal structure of rhodopsin: A G protein-coupled receptor. Science, 2000, 289 (5480), 739-745.
63. Natochin, M.; Gasimov, K. G.; Moussaif, M.; Artemyev, N. O., Rhodopsin determinants for transducin activation: a gain-offunction approach. J. Biol. Chem., 2003, 278 (39), 37574-37581.
64. Arora, P.; Ricks, T. K.; Trejo, J., Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer J. Cell Sci., 2007, 120, 921-928.
65. Swift, S.; Leger, A. J.; Talavera, J.; Zhang, L.; Bohm, A.; Kuliopulos, A., Role of the PAR1 receptor 8th helix in signaling: the 7-8-1 receptor activation mechanism. J. Biol. Chem., 2006, 281 (7), 4109-4116.
66. Jing, S. Q.; Trowbridge, I. S., Non acylated human transferring receptors are rapidly internalized and mediate iron uptake. J. Biol. Chem., 1990, 265 (20), 11555-11559.
67. Deng, X.; Mercer, P. F.; Scotton, C. J.; Gilchrist, A.; Chambers, R. C., Thrombin induces fibroblast CCL2/JE production and release via coupling of PAR1 to Galphaq and cooperation between ERK1/2 and Rho kinase signaling pathways. Mol. Biol. Cell., 2008, 19 (6), 2520-2533.
68. Scotton, C. J.; Krupiczojc, M. A.; Konigshoff, M.; Mercer, P. F.; Lee, Y. C.; Kaminski, N.; Morser, J.; Post, J. M.; Maher, T. M.; Nicholson, A. G.; Moffatt, J. D.; Laurent, G. J.; Derian, C. K.; Eickelberg, O.; Chambers, R. C., Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J. Clin. Invest., 2009, 119 (9), 2550-2563.
69. Dowal, L.; Sim, D. S.; Dilks, J. R.; Blair, P.; Beaudry, S.; Denker, B. M.; Koukos, G.; Kuliopulos, A.; Flaumenhaft, R., Identification of an antithrombotic allosteric modulator that acts through helix 8 of PAR1. Proc. Natl. Acad. Sci. U S A, 2011, 108 (7), 2951-2956.
70. Soh, U. J. K.; Trejo, J. Activated protein C promotes proteaseactivated receptor-1 cytoprotective signaling through beta-arrestin and dishevelled-2 scaffolds. Proc. Natl. Acad. Sci. USA, 2011, 108, E1372-E1380.
71. Adams, M.N.; Christensen, M.E.; He, Y.; Waterhouse, N.J.; Hooper, J.D. The Role of Palmitoylation in Signalling, Cellular Trafficking and Plasma Membrane Localization of Proteaseactivated Receptor-2. PLOS One 2011, 6, e28018, 1-13.